BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human...

Full description

Saved in:
Bibliographic Details
Published inCancer discovery Vol. 7; no. 10; pp. 1184 - 1199
Main Authors Chiou, Shin-Heng, Risca, Viviana I., Wang, Gordon X., Yang, Dian, Grüner, Barbara M., Kathiria, Arwa S., Ma, Rosanna K., Vaka, Dedeepya, Chu, Pauline, Kozak, Margaret, Castellini, Laura, Graves, Edward E., Kim, Grace E., Mourrain, Philippe, Koong, Albert C., Giaccia, Amato J., Winslow, Monte M.
Format Journal Article
LanguageEnglish
Published United States 01.10.2017
Online AccessGet full text
ISSN2159-8274
2159-8290
2159-8290
DOI10.1158/2159-8290.CD-17-0250

Cover

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor BLIMP1 as a driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes, and hypoxia-mediated induction of BLIMP1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which upregulation of BLIMP1 links microenvironmental cues to a metastatic stem cell character. Significance: PDAC is an almost uniformly lethal cancer, largely due to its tendency for metastasis. We define a highly metastatic subpopulation of cancer cells, uncover a key transcriptional regulator of metastatic ability, and define hypoxia as an important factor within the tumor microenvironment that increases metastatic proclivity. Cancer Discov; 7(10); 1184–99. ©2017 AACR. See related commentary by Vakoc and Tuveson, p. 1067. This article is highlighted in the In This Issue feature, p. 1047
AbstractList Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor BLIMP1 as a driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes, and hypoxia-mediated induction of BLIMP1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which upregulation of BLIMP1 links microenvironmental cues to a metastatic stem cell character. Significance: PDAC is an almost uniformly lethal cancer, largely due to its tendency for metastasis. We define a highly metastatic subpopulation of cancer cells, uncover a key transcriptional regulator of metastatic ability, and define hypoxia as an important factor within the tumor microenvironment that increases metastatic proclivity. Cancer Discov; 7(10); 1184–99. ©2017 AACR. See related commentary by Vakoc and Tuveson, p. 1067. This article is highlighted in the In This Issue feature, p. 1047
Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor BLIMP1 as a driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes, and hypoxia-mediated induction of BLIMP1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which upregulation of BLIMP1 links microenvironmental cues to a metastatic stem cell character. PDAC is an almost uniformly lethal cancer, largely due to its tendency for metastasis. We define a highly metastatic subpopulation of cancer cells, uncover a key transcriptional regulator of metastatic ability, and define hypoxia as an important factor within the tumor microenvironment that increases metastatic proclivity. .
Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. Using a novel genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor Blimp1 as a key driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes and hypoxia-mediated induction of Blimp1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which up-regulation of Blimp1 links microenvironmental cues to a metastatic stem cell character.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor BLIMP1 as a driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes, and hypoxia-mediated induction of BLIMP1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which upregulation of BLIMP1 links microenvironmental cues to a metastatic stem cell character.Significance: PDAC is an almost uniformly lethal cancer, largely due to its tendency for metastasis. We define a highly metastatic subpopulation of cancer cells, uncover a key transcriptional regulator of metastatic ability, and define hypoxia as an important factor within the tumor microenvironment that increases metastatic proclivity. Cancer Discov; 7(10); 1184-99. ©2017 AACR.See related commentary by Vakoc and Tuveson, p. 1067This article is highlighted in the In This Issue feature, p. 1047.Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our understanding of molecular mechanisms that drive PDAC metastatic ability remains limited. By generating a genetically engineered mouse model of human PDAC, we uncover a transient subpopulation of cancer cells with exceptionally high metastatic ability. Global gene expression profiling and functional analyses uncovered the transcription factor BLIMP1 as a driver of PDAC metastasis. The highly metastatic PDAC subpopulation is enriched for hypoxia-induced genes, and hypoxia-mediated induction of BLIMP1 contributes to the regulation of a subset of hypoxia-associated gene expression programs. These findings support a model in which upregulation of BLIMP1 links microenvironmental cues to a metastatic stem cell character.Significance: PDAC is an almost uniformly lethal cancer, largely due to its tendency for metastasis. We define a highly metastatic subpopulation of cancer cells, uncover a key transcriptional regulator of metastatic ability, and define hypoxia as an important factor within the tumor microenvironment that increases metastatic proclivity. Cancer Discov; 7(10); 1184-99. ©2017 AACR.See related commentary by Vakoc and Tuveson, p. 1067This article is highlighted in the In This Issue feature, p. 1047.
Author Koong, Albert C.
Winslow, Monte M.
Chiou, Shin-Heng
Kathiria, Arwa S.
Chu, Pauline
Castellini, Laura
Mourrain, Philippe
Ma, Rosanna K.
Risca, Viviana I.
Kozak, Margaret
Vaka, Dedeepya
Grüner, Barbara M.
Wang, Gordon X.
Yang, Dian
Kim, Grace E.
Giaccia, Amato J.
Graves, Edward E.
AuthorAffiliation 4 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
7 Department of Pathology, University of California San Francisco, San Francisco, CA, USA
6 Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
1 Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
3 Cancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA
2 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
5 Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA
AuthorAffiliation_xml – name: 3 Cancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA
– name: 7 Department of Pathology, University of California San Francisco, San Francisco, CA, USA
– name: 2 Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
– name: 1 Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
– name: 5 Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA
– name: 6 Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
– name: 4 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
Author_xml – sequence: 1
  givenname: Shin-Heng
  surname: Chiou
  fullname: Chiou, Shin-Heng
– sequence: 2
  givenname: Viviana I.
  surname: Risca
  fullname: Risca, Viviana I.
– sequence: 3
  givenname: Gordon X.
  surname: Wang
  fullname: Wang, Gordon X.
– sequence: 4
  givenname: Dian
  surname: Yang
  fullname: Yang, Dian
– sequence: 5
  givenname: Barbara M.
  surname: Grüner
  fullname: Grüner, Barbara M.
– sequence: 6
  givenname: Arwa S.
  surname: Kathiria
  fullname: Kathiria, Arwa S.
– sequence: 7
  givenname: Rosanna K.
  surname: Ma
  fullname: Ma, Rosanna K.
– sequence: 8
  givenname: Dedeepya
  surname: Vaka
  fullname: Vaka, Dedeepya
– sequence: 9
  givenname: Pauline
  surname: Chu
  fullname: Chu, Pauline
– sequence: 10
  givenname: Margaret
  surname: Kozak
  fullname: Kozak, Margaret
– sequence: 11
  givenname: Laura
  surname: Castellini
  fullname: Castellini, Laura
– sequence: 12
  givenname: Edward E.
  surname: Graves
  fullname: Graves, Edward E.
– sequence: 13
  givenname: Grace E.
  surname: Kim
  fullname: Kim, Grace E.
– sequence: 14
  givenname: Philippe
  surname: Mourrain
  fullname: Mourrain, Philippe
– sequence: 15
  givenname: Albert C.
  surname: Koong
  fullname: Koong, Albert C.
– sequence: 16
  givenname: Amato J.
  surname: Giaccia
  fullname: Giaccia, Amato J.
– sequence: 17
  givenname: Monte M.
  surname: Winslow
  fullname: Winslow, Monte M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28790031$$D View this record in MEDLINE/PubMed
BookMark eNp9Uc9PwyAUJkbjdPofGNOjlypQGNSDiVbnlmxxBz0TSl8V01GF1mT_va1zi3qQC-_xvh_kfYdo19UOEDoh-JwQLi8o4WksaYrPs9uYiBhTjnfQwfZ5d1sLNkDHIbzi7rCUcSz20YBKkWKckAM0vplN5wsSTV3RGgjRo9cuWHBNNIdGh0Y31kQTaMDXz-DANqvIumihnfHwNcu6EvwR2it1FeD4-x6ip_HdYzaJZw_30-x6FhsmWBPnpCwLiakYJSXoMs9zmRoQknJZ6EJrzHjXADEiFzrHBCc0GRUFAWBGsoIkQ3S11n1r8yUUpvuo15V683ap_UrV2qrfE2df1HP9ofiISsJ4J3D2LeDr9xZCo5Y2GKgq7aBugyIpFTzlGKcd9PSn19Zks7wOcLkGGF-H4KFUxvYLq3trWymCVR-W6pNQfSoqu1VEqD6sjsz-kDf6_9I-Adzul_w
CitedBy_id crossref_primary_10_1038_s41392_019_0095_0
crossref_primary_10_3892_ol_2021_13030
crossref_primary_10_1158_0008_5472_CAN_23_3578
crossref_primary_10_1016_j_pathol_2021_09_012
crossref_primary_10_1038_s41568_024_00781_9
crossref_primary_10_1158_2159_8290_CD_17_0887
crossref_primary_10_1038_s41416_020_01048_4
crossref_primary_10_1053_j_gastro_2017_11_280
crossref_primary_10_1007_s00330_022_08745_z
crossref_primary_10_1053_j_gastro_2019_05_004
crossref_primary_10_1016_j_bbrc_2018_05_024
crossref_primary_10_1038_s41416_020_01127_6
crossref_primary_10_1007_s11515_018_1513_3
crossref_primary_10_3389_fcell_2022_991664
crossref_primary_10_1146_annurev_pathmechdis_031621_024600
crossref_primary_10_1007_s10555_023_10132_z
crossref_primary_10_1158_2159_8290_CD_20_1826
crossref_primary_10_7554_eLife_84280
crossref_primary_10_26508_lsa_202201550
crossref_primary_10_1016_j_trecan_2021_01_008
crossref_primary_10_1038_s41568_018_0056_x
crossref_primary_10_3390_ijms25136881
crossref_primary_10_1016_j_canlet_2020_04_018
crossref_primary_10_1097_JS9_0000000000002059
crossref_primary_10_5306_wjco_v15_i4_531
crossref_primary_10_1016_j_bbagen_2023_130375
crossref_primary_10_3390_genes11010006
crossref_primary_10_1186_s13045_020_01030_w
crossref_primary_10_1007_s10585_023_10224_8
crossref_primary_10_3892_br_2022_1564
crossref_primary_10_1158_0008_5472_CAN_20_3209
crossref_primary_10_1038_s41598_018_32159_x
crossref_primary_10_1038_s41467_018_07511_4
crossref_primary_10_1007_s00432_022_03993_4
crossref_primary_10_1038_s41598_025_87337_5
crossref_primary_10_3390_cancers13010089
crossref_primary_10_1186_s12893_020_00856_y
crossref_primary_10_1038_s41556_024_01426_7
crossref_primary_10_1038_s41568_023_00568_4
crossref_primary_10_1007_s00292_020_00837_1
crossref_primary_10_1158_2159_8290_CD_20_1098
crossref_primary_10_1038_s41388_022_02448_x
crossref_primary_10_3892_or_2022_8451
crossref_primary_10_1073_pnas_1821893117
crossref_primary_10_3390_jpm11060571
crossref_primary_10_3390_jpm14030224
crossref_primary_10_1172_JCI177992
crossref_primary_10_3390_cells8091104
crossref_primary_10_3390_ijms252011143
Cites_doi 10.1158/1078-0432.CCR-07-4667
10.1002/mc.20235
10.1074/jbc.M010189200
10.1016/j.neuron.2007.06.014
10.1016/S1535-6108(03)00309-X
10.1038/nmeth.4297
10.1038/ng.3753
10.1172/JCI69244
10.1038/onc.2009.252
10.1038/nature17988
10.1016/j.stem.2010.08.009
10.1038/ncb1413
10.1038/nm.4285
10.1101/gad.943001
10.1038/nmeth.2688
10.1038/jid.2013.197
10.1016/j.cellsig.2011.08.019
10.3892/ol_00000122
10.1056/NEJMra0901557
10.1158/2159-8290.CD-15-0120
10.4161/cc.8.20.9701
10.1038/nm.3394
10.1038/nature14169
10.1101/gad.1158703
10.1101/gad.264861.115
10.4049/jimmunol.167.11.6140
10.1038/nrc2540
10.1016/j.ccell.2015.06.009
10.1101/gad.1478706
10.1073/pnas.1305172110
10.1200/JCO.2008.16.6702
10.1016/S0360-3016(00)00803-8
10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X
10.1016/j.cell.2009.11.007
10.1038/nature03813
10.1097/00000658-199602000-00006
10.1371/journal.pone.0002853
10.1038/nature13611
10.1016/j.celrep.2014.05.031
10.1016/j.stem.2007.06.002
10.2217/fon.13.92
10.1016/S1074-7613(02)00335-7
10.1038/sj.bjc.6601391
10.1126/science.276.5312.596
10.1172/JCI17669
10.1038/nn.2467
10.1073/pnas.0601273103
10.1158/0008-5472.CAN-10-4261
10.1038/onc.2010.449
10.1038/ncomms12685
10.1242/dev.01711
10.1016/j.ccr.2005.04.023
10.1016/S0002-9440(10)64123-5
10.1038/nature09460
10.1038/nature19334
10.4049/jimmunol.173.9.5556
10.1038/nature09515
10.1158/1078-0432.CCR-11-3114
10.1038/modpathol.2008.140
10.1158/0008-5472.CAN-12-2270
10.1016/j.canlet.2013.07.028
10.1016/j.stem.2009.08.001
10.1158/1078-0432.CCR-10-2542
10.1016/j.cell.2004.11.004
10.1038/ng.3764
10.1111/j.1365-2559.2011.04121.x
10.1073/pnas.0501283102
10.1016/S1074-7613(03)00267-X
10.1158/0008-5472.CAN-10-4049
10.1038/ni.3349
10.1038/nature19823
10.1182/blood.V82.7.2031.2031
10.1158/1078-0432.CCR-13-2947
10.1371/journal.pone.0033287
10.1158/0008-5472.CAN-14-0155
10.1016/j.cell.2015.04.048
10.1172/JCI78031
10.1038/nature16064
10.1038/nature09535
ContentType Journal Article
Copyright 2017 American Association for Cancer Research.
Copyright_xml – notice: 2017 American Association for Cancer Research.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1158/2159-8290.CD-17-0250
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2159-8290
EndPage 1199
ExternalDocumentID PMC5628145
28790031
10_1158_2159_8290_CD_17_0250
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R00 CA151968
– fundername: NCI NIH HHS
  grantid: P01 CA067166
– fundername: NCI NIH HHS
  grantid: R01 CA197136
– fundername: NIMH NIH HHS
  grantid: R01 MH099647
– fundername: NCI NIH HHS
  grantid: R01 CA198291
– fundername: NCI NIH HHS
  grantid: P30 CA124435
GroupedDBID ---
53G
5VS
AAYXX
ADBBV
ADCOW
AENEX
AFHIN
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BR6
BTFSW
CITATION
EBS
EJD
H13
KQ8
OK1
RCR
RHI
NPM
7X8
5PM
ID FETCH-LOGICAL-c474t-b1ffd802763feafbbb89ce78258dadaa045782e1c7b7ab0103236dd1ee4c84d13
ISSN 2159-8274
2159-8290
IngestDate Thu Aug 21 13:50:47 EDT 2025
Fri Sep 05 10:49:22 EDT 2025
Thu Apr 03 07:06:20 EDT 2025
Thu Apr 24 22:57:43 EDT 2025
Tue Jul 01 00:56:21 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 10
Language English
License 2017 American Association for Cancer Research.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-b1ffd802763feafbbb89ce78258dadaa045782e1c7b7ab0103236dd1ee4c84d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/5628145
PMID 28790031
PQID 1927595009
PQPubID 23479
PageCount 16
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5628145
proquest_miscellaneous_1927595009
pubmed_primary_28790031
crossref_citationtrail_10_1158_2159_8290_CD_17_0250
crossref_primary_10_1158_2159_8290_CD_17_0250
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-01
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer discovery
PublicationTitleAlternate Cancer Discov
PublicationYear 2017
References Bertout (2022060700365763800_bib62) 2008; 8
Luttges (2022060700365763800_bib6) 2001; 158
Viale (2022060700365763800_bib35) 2014; 514
Kawamura (2022060700365763800_bib49) 2001; 92
Bardeesy (2022060700365763800_bib23) 2006; 103
Motoyama (2022060700365763800_bib27) 2008; 14
Ancelin (2022060700365763800_bib43) 2006; 8
Meyer (2022060700365763800_bib26) 2007; 46
Whittle (2022060700365763800_bib13) 2015; 161
Maddipati (2022060700365763800_bib61) 2015; 5
Moskaluk (2022060700365763800_bib3) 1997; 57
Feldser (2022060700365763800_bib56) 2010; 468
Aguirre (2022060700365763800_bib22) 2003; 17
Piscuoglio (2022060700365763800_bib28) 2012; 60
Chiou (2022060700365763800_bib60) 2015; 29
Makohon-Moore (2022060700365763800_bib10) 2017; 49
Ohinata (2022060700365763800_bib38) 2005; 436
Wang (2022060700365763800_bib30) 2011; 17
Arulanandam (2022060700365763800_bib41) 2015; 28
Gardner (2022060700365763800_bib39) 2001; 276
Cipolleschi (2022060700365763800_bib67) 1993; 82
Banerjee (2022060700365763800_bib33) 2014; 20
Cho (2022060700365763800_bib78) 2016; 537
Minnich (2022060700365763800_bib44) 2016; 17
Wilentz (2022060700365763800_bib5) 2000; 60
Raskin (2022060700365763800_bib24) 2013; 133
Muzumdar (2022060700365763800_bib57) 2016; 7
Jackson (2022060700365763800_bib79) 2001; 15
Heddleston (2022060700365763800_bib71) 2009; 8
Madisen (2022060700365763800_bib32) 2010; 13
Fortner (2022060700365763800_bib59) 1996; 223
Danet (2022060700365763800_bib66) 2003; 112
Yu (2022060700365763800_bib74) 2012; 7
Olive (2022060700365763800_bib80) 2004; 119
Feig (2022060700365763800_bib17) 2012; 18
Yoshida (2022060700365763800_bib69) 2009; 5
Rahib (2022060700365763800_bib1) 2014; 74
Shapiro-Shelef (2022060700365763800_bib37) 2003; 19
Micheva (2022060700365763800_bib40) 2007; 55
Abe (2022060700365763800_bib31) 2003; 89
Thiery (2022060700365763800_bib11) 2009; 139
Campbell (2022060700365763800_bib8) 2010; 467
Lou (2022060700365763800_bib48) 2011; 71
Bardeesy (2022060700365763800_bib21) 2006; 20
Chuang (2022060700365763800_bib55) 2017; 23
Hingorani (2022060700365763800_bib18) 2003; 4
Ishizawa (2022060700365763800_bib72) 2010; 7
Lee (2022060700365763800_bib34) 2008; 26
Zheng (2022060700365763800_bib12) 2015; 527
Lin (2022060700365763800_bib45) 1997; 276
Quail (2022060700365763800_bib16) 2013; 19
Hingorani (2022060700365763800_bib19) 2005; 7
Chang (2022060700365763800_bib64) 2011; 71
Walls (2022060700365763800_bib75) 2008; 3
Moncho-Amor (2022060700365763800_bib51) 2011; 30
Hermann (2022060700365763800_bib15) 2007; 1
Koong (2022060700365763800_bib63) 2000; 48
Notta (2022060700365763800_bib9) 2016; 538
Caldwell (2022060700365763800_bib77) 2001; 167
McDonald (2022060700365763800_bib36) 2017; 49
Chaturvedi (2022060700365763800_bib50) 2013; 123
Yachida (2022060700365763800_bib7) 2010; 467
Hidalgo (2022060700365763800_bib2) 2010; 362
Romagnoli (2022060700365763800_bib73) 2012; 72
Hristov (2022060700365763800_bib25) 2009; 22
Gilkes (2022060700365763800_bib65) 2013; 9
Buenrostro (2022060700365763800_bib81) 2013; 10
Chiou (2022060700365763800_bib20) 2014; 7
Fox (2022060700365763800_bib14) 2016; 534
Melvin (2022060700365763800_bib42) 2012; 24
Waddell (2022060700365763800_bib4) 2015; 518
Vincent (2022060700365763800_bib76) 2005; 132
Seo (2022060700365763800_bib53) 2010; 1
Soeda (2022060700365763800_bib70) 2009; 28
Kuo (2022060700365763800_bib47) 2004; 173
Shaffer (2022060700365763800_bib46) 2002; 17
Sun (2022060700365763800_bib29) 2013; 110
Kim (2022060700365763800_bib54) 2013; 341
Rogers (2022060700365763800_bib58) 2017; 14
Dey (2022060700365763800_bib52) 2015; 125
Ezashi (2022060700365763800_bib68) 2005; 102
23054396 - Cancer Res. 2012 Dec 1;72(23):6268-78
28092682 - Nat Genet. 2017 Mar;49(3):358-366
11714773 - J Immunol. 2001 Dec 1;167(11):6140-9
19718046 - Oncogene. 2009 Nov 12;28(45):3949-59
20023653 - Nat Neurosci. 2010 Jan;13(1):133-40
26011642 - J Clin Invest. 2015 Jul 1;125(7):2592-608
15607980 - Cell. 2004 Dec 17;119(6):847-60
11112789 - J Biol Chem. 2001 Mar 16;276(11):7919-26
11072146 - Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):919-22
21252160 - Clin Cancer Res. 2011 Apr 15;17(8):2570-80
20981102 - Nature. 2010 Oct 28;467(7319):1114-7
27585860 - Nat Commun. 2016 Sep 02;7:12685
24156323 - Future Oncol. 2013 Nov;9(11):1623-36
12150891 - Immunity. 2002 Jul;17(1):51-62
24634377 - Clin Cancer Res. 2014 May 1;20(9):2388-99
26209539 - Cancer Discov. 2015 Oct;5(10):1086-97
26779602 - Nat Immunol. 2016 Mar;17(3):331-43
18682734 - PLoS One. 2008 Aug 06;3(8):e2853
15937476 - Nature. 2005 Jul 14;436(7048):207-13
28092686 - Nat Genet. 2017 Mar;49(3):367-376
28191885 - Nat Med. 2017 Mar;23 (3):291-300
20981101 - Nature. 2010 Oct 28;467(7319):1109-13
25719666 - Nature. 2015 Feb 26;518(7540):495-501
15494505 - J Immunol. 2004 Nov 1;173(9):5556-63
24840647 - Cancer Res. 2014 Jun 1;74(11):2913-21
26178787 - Genes Dev. 2015 Jul 15;29(14):1576-85
28974531 - Cancer Discov. 2017 Oct;7(10 ):1067-1068
20890299 - Oncogene. 2011 Feb 10;30(6):668-78
8597508 - Ann Surg. 1996 Feb;223(2):147-53
9110979 - Science. 1997 Apr 25;276(5312):596-9
22438909 - PLoS One. 2012;7(3):e33287
17114584 - Genes Dev. 2006 Nov 15;20(22):3130-46
17477356 - Mol Carcinog. 2007 Jul;46(7):503-11
24202395 - Nat Med. 2013 Nov;19(11):1423-37
14681207 - Genes Dev. 2003 Dec 15;17(24):3112-26
11751630 - Genes Dev. 2001 Dec 15;15(24):3243-8
27732578 - Nature. 2016 Oct 20;538(7625):378-382
14706336 - Cancer Cell. 2003 Dec;4(6):437-50
24097267 - Nat Methods. 2013 Dec;10(12):1213-8
19716359 - Cell Stem Cell. 2009 Sep 4;5(3):237-41
15772165 - Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4783-8
18843278 - Mod Pathol. 2009 Jan;22(1):43-9
18413822 - Clin Cancer Res. 2008 Apr 15;14(8):2334-40
23633021 - J Invest Dermatol. 2013 Nov;133(11):2585-2592
12840067 - J Clin Invest. 2003 Jul;112(1):126-35
18539958 - J Clin Oncol. 2008 Jun 10;26(17):2806-12
22896693 - Clin Cancer Res. 2012 Aug 15;18(16):4266-76
20427809 - N Engl J Med. 2010 Apr 29;362(17):1605-17
18987634 - Nat Rev Cancer. 2008 Dec;8(12):967-75
19945376 - Cell. 2009 Nov 25;139(5):871-90
24931605 - Cell Rep. 2014 Jun 26;7(6):2078-86
16585505 - Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5947-52
23916472 - Cancer Lett. 2013 Dec 1;341(2):159-65
11505409 - Cancer. 2001 Aug 1;92(3):634-41
15894267 - Cancer Cell. 2005 May;7(5):469-83
21343390 - Cancer Res. 2011 Apr 15;71(8):3110-20
23716660 - Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9920-5
11337365 - Am J Pathol. 2001 May;158(5):1677-83
28530655 - Nat Methods. 2017 Jul;14 (7):737-742
27281208 - Nature. 2016 Jun 06;534(7607):407-411
23318994 - J Clin Invest. 2013 Jan;123(1):189-205
22966366 - Oncol Lett. 2010 Jul;1(4):697-701
8104535 - Blood. 1993 Oct 1;82(7):2031-7
20804964 - Cell Stem Cell. 2010 Sep 3;7(3):279-82
9187111 - Cancer Res. 1997 Jun 1;57(11):2140-3
26004068 - Cell. 2015 Jun 4;161(6):1345-60
16699504 - Nat Cell Biol. 2006 Jun;8(6):623-30
21924352 - Cell Signal. 2012 Jan;24(1):35-43
14647145 - Br J Cancer. 2003 Dec 1;89(11):2104-9
21107428 - Nature. 2010 Nov 25;468(7323):572-5
27501247 - Nature. 2016 Sep 8;537(7619):234-238
15750184 - Development. 2005 Mar;132(6):1315-25
26212250 - Cancer Cell. 2015 Aug 10;28(2):210-24
18371365 - Cell Stem Cell. 2007 Sep 13;1(3):313-23
21415165 - Cancer Res. 2011 May 1;71(9):3364-76
14563324 - Immunity. 2003 Oct;19(4):607-20
25119024 - Nature. 2014 Oct 30;514(7524):628-32
10766191 - Cancer Res. 2000 Apr 1;60(7):2002-6
19770585 - Cell Cycle. 2009 Oct 15;8(20):3274-84
17610815 - Neuron. 2007 Jul 5;55(1):25-36
26560028 - Nature. 2015 Nov 26;527(7579):525-530
22276603 - Histopathology. 2012 Feb;60(3):397-404
References_xml – volume: 14
  start-page: 2334
  year: 2008
  ident: 2022060700365763800_bib27
  article-title: Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-4667
– volume: 46
  start-page: 503
  year: 2007
  ident: 2022060700365763800_bib26
  article-title: HMGA2 overexpression in non-small cell lung cancer
  publication-title: Mol Carcinog
  doi: 10.1002/mc.20235
– volume: 276
  start-page: 7919
  year: 2001
  ident: 2022060700365763800_bib39
  article-title: Hypoxia inhibits G1/S transition through regulation of p27 expression
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M010189200
– volume: 55
  start-page: 25
  year: 2007
  ident: 2022060700365763800_bib40
  article-title: Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits
  publication-title: Neuron
  doi: 10.1016/j.neuron.2007.06.014
– volume: 4
  start-page: 437
  year: 2003
  ident: 2022060700365763800_bib18
  article-title: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00309-X
– volume: 14
  start-page: 737
  year: 2017
  ident: 2022060700365763800_bib58
  article-title: A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo
  publication-title: Nat Methods
  doi: 10.1038/nmeth.4297
– volume: 49
  start-page: 367
  year: 2017
  ident: 2022060700365763800_bib36
  article-title: Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
  publication-title: Nat Genet
  doi: 10.1038/ng.3753
– volume: 123
  start-page: 189
  year: 2013
  ident: 2022060700365763800_bib50
  article-title: Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis
  publication-title: J Clin Invest
  doi: 10.1172/JCI69244
– volume: 28
  start-page: 3949
  year: 2009
  ident: 2022060700365763800_bib70
  article-title: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha
  publication-title: Oncogene
  doi: 10.1038/onc.2009.252
– volume: 534
  start-page: 407
  year: 2016
  ident: 2022060700365763800_bib14
  article-title: Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma
  publication-title: Nature
  doi: 10.1038/nature17988
– volume: 7
  start-page: 279
  year: 2010
  ident: 2022060700365763800_bib72
  article-title: Tumor-initiating cells are rare in many human tumors
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.08.009
– volume: 8
  start-page: 623
  year: 2006
  ident: 2022060700365763800_bib43
  article-title: Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1413
– volume: 23
  start-page: 291
  year: 2017
  ident: 2022060700365763800_bib55
  article-title: Molecular definition of a metastatic lung cancer state reveals a targetable CD109/Jak/Stat axis
  publication-title: Nat Med
  doi: 10.1038/nm.4285
– volume: 15
  start-page: 3243
  year: 2001
  ident: 2022060700365763800_bib79
  article-title: Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
  publication-title: Genes Dev
  doi: 10.1101/gad.943001
– volume: 10
  start-page: 1213
  year: 2013
  ident: 2022060700365763800_bib81
  article-title: Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
  publication-title: Nat Methods
  doi: 10.1038/nmeth.2688
– volume: 133
  start-page: 2585
  year: 2013
  ident: 2022060700365763800_bib24
  article-title: Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2013.197
– volume: 24
  start-page: 35
  year: 2012
  ident: 2022060700365763800_bib42
  article-title: Chromatin as an oxygen sensor and active player in the hypoxia response
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2011.08.019
– volume: 1
  start-page: 697
  year: 2010
  ident: 2022060700365763800_bib53
  article-title: Expression of hypoxia-inducible protein 2 in renal cell carcinoma: a promising candidate for molecular targeting therapy
  publication-title: Oncol Lett
  doi: 10.3892/ol_00000122
– volume: 362
  start-page: 1605
  year: 2010
  ident: 2022060700365763800_bib2
  article-title: Pancreatic cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0901557
– volume: 5
  start-page: 1086
  year: 2015
  ident: 2022060700365763800_bib61
  article-title: Pancreatic cancer metastases harbor evidence of polyclonality
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-15-0120
– volume: 8
  start-page: 3274
  year: 2009
  ident: 2022060700365763800_bib71
  article-title: The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
  publication-title: Cell Cycle
  doi: 10.4161/cc.8.20.9701
– volume: 19
  start-page: 1423
  year: 2013
  ident: 2022060700365763800_bib16
  article-title: Microenvironmental regulation of tumor progression and metastasis
  publication-title: Nat Med
  doi: 10.1038/nm.3394
– volume: 518
  start-page: 495
  year: 2015
  ident: 2022060700365763800_bib4
  article-title: Whole genomes redefine the mutational landscape of pancreatic cancer
  publication-title: Nature
  doi: 10.1038/nature14169
– volume: 17
  start-page: 3112
  year: 2003
  ident: 2022060700365763800_bib22
  article-title: Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
  publication-title: Genes Dev
  doi: 10.1101/gad.1158703
– volume: 29
  start-page: 1576
  year: 2015
  ident: 2022060700365763800_bib60
  article-title: Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
  publication-title: Genes Dev
  doi: 10.1101/gad.264861.115
– volume: 167
  start-page: 6140
  year: 2001
  ident: 2022060700365763800_bib77
  article-title: Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions
  publication-title: J Immunol
  doi: 10.4049/jimmunol.167.11.6140
– volume: 8
  start-page: 967
  year: 2008
  ident: 2022060700365763800_bib62
  article-title: The impact of O2 availability on human cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2540
– volume: 28
  start-page: 210
  year: 2015
  ident: 2022060700365763800_bib41
  article-title: VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2015.06.009
– volume: 20
  start-page: 3130
  year: 2006
  ident: 2022060700365763800_bib21
  article-title: Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
  publication-title: Genes Dev
  doi: 10.1101/gad.1478706
– volume: 110
  start-page: 9920
  year: 2013
  ident: 2022060700365763800_bib29
  article-title: HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1305172110
– volume: 26
  start-page: 2806
  year: 2008
  ident: 2022060700365763800_bib34
  article-title: Pancreatic cancer stem cells
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.16.6702
– volume: 60
  start-page: 2002
  year: 2000
  ident: 2022060700365763800_bib5
  article-title: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression
  publication-title: Cancer Res
– volume: 48
  start-page: 919
  year: 2000
  ident: 2022060700365763800_bib63
  article-title: Pancreatic tumors show high levels of hypoxia
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(00)00803-8
– volume: 92
  start-page: 634
  year: 2001
  ident: 2022060700365763800_bib49
  article-title: Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival
  publication-title: Cancer
  doi: 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X
– volume: 139
  start-page: 871
  year: 2009
  ident: 2022060700365763800_bib11
  article-title: Epithelial-mesenchymal transitions in development and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
– volume: 436
  start-page: 207
  year: 2005
  ident: 2022060700365763800_bib38
  article-title: Blimp1 is a critical determinant of the germ cell lineage in mice
  publication-title: Nature
  doi: 10.1038/nature03813
– volume: 223
  start-page: 147
  year: 1996
  ident: 2022060700365763800_bib59
  article-title: Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy
  publication-title: Ann Surg
  doi: 10.1097/00000658-199602000-00006
– volume: 3
  start-page: e2853
  year: 2008
  ident: 2022060700365763800_bib75
  article-title: Three-dimensional analysis of vascular development in the mouse embryo
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002853
– volume: 514
  start-page: 628
  year: 2014
  ident: 2022060700365763800_bib35
  article-title: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
  publication-title: Nature
  doi: 10.1038/nature13611
– volume: 7
  start-page: 2078
  year: 2014
  ident: 2022060700365763800_bib20
  article-title: A conditional system to specifically link disruption of protein-coding function with reporter expression in mice
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.05.031
– volume: 1
  start-page: 313
  year: 2007
  ident: 2022060700365763800_bib15
  article-title: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.06.002
– volume: 9
  start-page: 1623
  year: 2013
  ident: 2022060700365763800_bib65
  article-title: Role of hypoxia-inducible factors in breast cancer metastasis
  publication-title: Future Oncol
  doi: 10.2217/fon.13.92
– volume: 17
  start-page: 51
  year: 2002
  ident: 2022060700365763800_bib46
  article-title: Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program
  publication-title: Immunity
  doi: 10.1016/S1074-7613(02)00335-7
– volume: 89
  start-page: 2104
  year: 2003
  ident: 2022060700365763800_bib31
  article-title: An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6601391
– volume: 276
  start-page: 596
  year: 1997
  ident: 2022060700365763800_bib45
  article-title: Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation
  publication-title: Science
  doi: 10.1126/science.276.5312.596
– volume: 112
  start-page: 126
  year: 2003
  ident: 2022060700365763800_bib66
  article-title: Expansion of human SCID-repopulating cells under hypoxic conditions
  publication-title: J Clin Invest
  doi: 10.1172/JCI17669
– volume: 13
  start-page: 133
  year: 2010
  ident: 2022060700365763800_bib32
  article-title: A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2467
– volume: 103
  start-page: 5947
  year: 2006
  ident: 2022060700365763800_bib23
  article-title: Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0601273103
– volume: 71
  start-page: 3364
  year: 2011
  ident: 2022060700365763800_bib48
  article-title: Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-4261
– volume: 30
  start-page: 668
  year: 2011
  ident: 2022060700365763800_bib51
  article-title: DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2010.449
– volume: 7
  start-page: 12685
  year: 2016
  ident: 2022060700365763800_bib57
  article-title: Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
  publication-title: Nat Commun
  doi: 10.1038/ncomms12685
– volume: 132
  start-page: 1315
  year: 2005
  ident: 2022060700365763800_bib76
  article-title: The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse
  publication-title: Development
  doi: 10.1242/dev.01711
– volume: 7
  start-page: 469
  year: 2005
  ident: 2022060700365763800_bib19
  article-title: Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.04.023
– volume: 158
  start-page: 1677
  year: 2001
  ident: 2022060700365763800_bib6
  article-title: Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64123-5
– volume: 467
  start-page: 1109
  year: 2010
  ident: 2022060700365763800_bib8
  article-title: The patterns and dynamics of genomic instability in metastatic pancreatic cancer
  publication-title: Nature
  doi: 10.1038/nature09460
– volume: 537
  start-page: 234
  year: 2016
  ident: 2022060700365763800_bib78
  article-title: Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system
  publication-title: Nature
  doi: 10.1038/nature19334
– volume: 173
  start-page: 5556
  year: 2004
  ident: 2022060700365763800_bib47
  article-title: B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.9.5556
– volume: 467
  start-page: 1114
  year: 2010
  ident: 2022060700365763800_bib7
  article-title: Distant metastasis occurs late during the genetic evolution of pancreatic cancer
  publication-title: Nature
  doi: 10.1038/nature09515
– volume: 18
  start-page: 4266
  year: 2012
  ident: 2022060700365763800_bib17
  article-title: The pancreas cancer microenvironment
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-3114
– volume: 22
  start-page: 43
  year: 2009
  ident: 2022060700365763800_bib25
  article-title: HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.2008.140
– volume: 72
  start-page: 6268
  year: 2012
  ident: 2022060700365763800_bib73
  article-title: Epithelial-to-mesenchymal transition induced by TGF-beta1 is mediated by Blimp-1-dependent repression of BMP-5
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-2270
– volume: 341
  start-page: 159
  year: 2013
  ident: 2022060700365763800_bib54
  article-title: HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.07.028
– volume: 5
  start-page: 237
  year: 2009
  ident: 2022060700365763800_bib69
  article-title: Hypoxia enhances the generation of induced pluripotent stem cells
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2009.08.001
– volume: 17
  start-page: 2570
  year: 2011
  ident: 2022060700365763800_bib30
  article-title: Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-10-2542
– volume: 119
  start-page: 847
  year: 2004
  ident: 2022060700365763800_bib80
  article-title: Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
  publication-title: Cell
  doi: 10.1016/j.cell.2004.11.004
– volume: 57
  start-page: 2140
  year: 1997
  ident: 2022060700365763800_bib3
  article-title: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
  publication-title: Cancer Res
– volume: 49
  start-page: 358
  year: 2017
  ident: 2022060700365763800_bib10
  article-title: Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
  publication-title: Nat Genet
  doi: 10.1038/ng.3764
– volume: 60
  start-page: 397
  year: 2012
  ident: 2022060700365763800_bib28
  article-title: HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2011.04121.x
– volume: 102
  start-page: 4783
  year: 2005
  ident: 2022060700365763800_bib68
  article-title: Low O2 tensions and the prevention of differentiation of hES cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0501283102
– volume: 19
  start-page: 607
  year: 2003
  ident: 2022060700365763800_bib37
  article-title: Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells
  publication-title: Immunity
  doi: 10.1016/S1074-7613(03)00267-X
– volume: 71
  start-page: 3110
  year: 2011
  ident: 2022060700365763800_bib64
  article-title: Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-4049
– volume: 17
  start-page: 331
  year: 2016
  ident: 2022060700365763800_bib44
  article-title: Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation
  publication-title: Nat Immunol
  doi: 10.1038/ni.3349
– volume: 538
  start-page: 378
  year: 2016
  ident: 2022060700365763800_bib9
  article-title: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
  publication-title: Nature
  doi: 10.1038/nature19823
– volume: 82
  start-page: 2031
  year: 1993
  ident: 2022060700365763800_bib67
  article-title: The role of hypoxia in the maintenance of hematopoietic stem cells
  publication-title: Blood
  doi: 10.1182/blood.V82.7.2031.2031
– volume: 20
  start-page: 2388
  year: 2014
  ident: 2022060700365763800_bib33
  article-title: CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-2947
– volume: 7
  start-page: e33287
  year: 2012
  ident: 2022060700365763800_bib74
  article-title: Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0033287
– volume: 74
  start-page: 2913
  year: 2014
  ident: 2022060700365763800_bib1
  article-title: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-0155
– volume: 161
  start-page: 1345
  year: 2015
  ident: 2022060700365763800_bib13
  article-title: RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma
  publication-title: Cell
  doi: 10.1016/j.cell.2015.04.048
– volume: 125
  start-page: 2592
  year: 2015
  ident: 2022060700365763800_bib52
  article-title: ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis
  publication-title: J Clin Invest
  doi: 10.1172/JCI78031
– volume: 527
  start-page: 525
  year: 2015
  ident: 2022060700365763800_bib12
  article-title: Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
  publication-title: Nature
  doi: 10.1038/nature16064
– volume: 468
  start-page: 572
  year: 2010
  ident: 2022060700365763800_bib56
  article-title: Stage-specific sensitivity to p53 restoration during lung cancer progression
  publication-title: Nature
  doi: 10.1038/nature09535
– reference: 28092686 - Nat Genet. 2017 Mar;49(3):367-376
– reference: 18987634 - Nat Rev Cancer. 2008 Dec;8(12):967-75
– reference: 24931605 - Cell Rep. 2014 Jun 26;7(6):2078-86
– reference: 14647145 - Br J Cancer. 2003 Dec 1;89(11):2104-9
– reference: 21415165 - Cancer Res. 2011 May 1;71(9):3364-76
– reference: 28092682 - Nat Genet. 2017 Mar;49(3):358-366
– reference: 26209539 - Cancer Discov. 2015 Oct;5(10):1086-97
– reference: 18413822 - Clin Cancer Res. 2008 Apr 15;14(8):2334-40
– reference: 21252160 - Clin Cancer Res. 2011 Apr 15;17(8):2570-80
– reference: 21343390 - Cancer Res. 2011 Apr 15;71(8):3110-20
– reference: 15494505 - J Immunol. 2004 Nov 1;173(9):5556-63
– reference: 26178787 - Genes Dev. 2015 Jul 15;29(14):1576-85
– reference: 27585860 - Nat Commun. 2016 Sep 02;7:12685
– reference: 16585505 - Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5947-52
– reference: 15937476 - Nature. 2005 Jul 14;436(7048):207-13
– reference: 10766191 - Cancer Res. 2000 Apr 1;60(7):2002-6
– reference: 26004068 - Cell. 2015 Jun 4;161(6):1345-60
– reference: 11751630 - Genes Dev. 2001 Dec 15;15(24):3243-8
– reference: 22276603 - Histopathology. 2012 Feb;60(3):397-404
– reference: 19716359 - Cell Stem Cell. 2009 Sep 4;5(3):237-41
– reference: 22966366 - Oncol Lett. 2010 Jul;1(4):697-701
– reference: 11714773 - J Immunol. 2001 Dec 1;167(11):6140-9
– reference: 20890299 - Oncogene. 2011 Feb 10;30(6):668-78
– reference: 22896693 - Clin Cancer Res. 2012 Aug 15;18(16):4266-76
– reference: 12840067 - J Clin Invest. 2003 Jul;112(1):126-35
– reference: 19718046 - Oncogene. 2009 Nov 12;28(45):3949-59
– reference: 8597508 - Ann Surg. 1996 Feb;223(2):147-53
– reference: 27732578 - Nature. 2016 Oct 20;538(7625):378-382
– reference: 11505409 - Cancer. 2001 Aug 1;92(3):634-41
– reference: 24202395 - Nat Med. 2013 Nov;19(11):1423-37
– reference: 21107428 - Nature. 2010 Nov 25;468(7323):572-5
– reference: 11072146 - Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):919-22
– reference: 14706336 - Cancer Cell. 2003 Dec;4(6):437-50
– reference: 18371365 - Cell Stem Cell. 2007 Sep 13;1(3):313-23
– reference: 26779602 - Nat Immunol. 2016 Mar;17(3):331-43
– reference: 20981102 - Nature. 2010 Oct 28;467(7319):1114-7
– reference: 11112789 - J Biol Chem. 2001 Mar 16;276(11):7919-26
– reference: 26212250 - Cancer Cell. 2015 Aug 10;28(2):210-24
– reference: 20023653 - Nat Neurosci. 2010 Jan;13(1):133-40
– reference: 17477356 - Mol Carcinog. 2007 Jul;46(7):503-11
– reference: 22438909 - PLoS One. 2012;7(3):e33287
– reference: 24097267 - Nat Methods. 2013 Dec;10(12):1213-8
– reference: 20981101 - Nature. 2010 Oct 28;467(7319):1109-13
– reference: 26011642 - J Clin Invest. 2015 Jul 1;125(7):2592-608
– reference: 17114584 - Genes Dev. 2006 Nov 15;20(22):3130-46
– reference: 25719666 - Nature. 2015 Feb 26;518(7540):495-501
– reference: 25119024 - Nature. 2014 Oct 30;514(7524):628-32
– reference: 15772165 - Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4783-8
– reference: 11337365 - Am J Pathol. 2001 May;158(5):1677-83
– reference: 24840647 - Cancer Res. 2014 Jun 1;74(11):2913-21
– reference: 16699504 - Nat Cell Biol. 2006 Jun;8(6):623-30
– reference: 19945376 - Cell. 2009 Nov 25;139(5):871-90
– reference: 24634377 - Clin Cancer Res. 2014 May 1;20(9):2388-99
– reference: 19770585 - Cell Cycle. 2009 Oct 15;8(20):3274-84
– reference: 9110979 - Science. 1997 Apr 25;276(5312):596-9
– reference: 26560028 - Nature. 2015 Nov 26;527(7579):525-530
– reference: 20804964 - Cell Stem Cell. 2010 Sep 3;7(3):279-82
– reference: 12150891 - Immunity. 2002 Jul;17(1):51-62
– reference: 28974531 - Cancer Discov. 2017 Oct;7(10 ):1067-1068
– reference: 15894267 - Cancer Cell. 2005 May;7(5):469-83
– reference: 17610815 - Neuron. 2007 Jul 5;55(1):25-36
– reference: 21924352 - Cell Signal. 2012 Jan;24(1):35-43
– reference: 23716660 - Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9920-5
– reference: 28191885 - Nat Med. 2017 Mar;23 (3):291-300
– reference: 20427809 - N Engl J Med. 2010 Apr 29;362(17):1605-17
– reference: 8104535 - Blood. 1993 Oct 1;82(7):2031-7
– reference: 15607980 - Cell. 2004 Dec 17;119(6):847-60
– reference: 14681207 - Genes Dev. 2003 Dec 15;17(24):3112-26
– reference: 23054396 - Cancer Res. 2012 Dec 1;72(23):6268-78
– reference: 27501247 - Nature. 2016 Sep 8;537(7619):234-238
– reference: 18843278 - Mod Pathol. 2009 Jan;22(1):43-9
– reference: 23916472 - Cancer Lett. 2013 Dec 1;341(2):159-65
– reference: 28530655 - Nat Methods. 2017 Jul;14 (7):737-742
– reference: 15750184 - Development. 2005 Mar;132(6):1315-25
– reference: 18539958 - J Clin Oncol. 2008 Jun 10;26(17):2806-12
– reference: 9187111 - Cancer Res. 1997 Jun 1;57(11):2140-3
– reference: 23318994 - J Clin Invest. 2013 Jan;123(1):189-205
– reference: 18682734 - PLoS One. 2008 Aug 06;3(8):e2853
– reference: 24156323 - Future Oncol. 2013 Nov;9(11):1623-36
– reference: 23633021 - J Invest Dermatol. 2013 Nov;133(11):2585-2592
– reference: 27281208 - Nature. 2016 Jun 06;534(7607):407-411
– reference: 14563324 - Immunity. 2003 Oct;19(4):607-20
SSID ssj0000494507
Score 2.417646
Snippet Pancreatic ductal adenocarcinoma (PDAC) is one of the most metastatic and deadly cancers. Despite the clinical significance of metastatic spread, our...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1184
Title BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/28790031
https://www.proquest.com/docview/1927595009
https://pubmed.ncbi.nlm.nih.gov/PMC5628145
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDflpSBxq7zUifM6QspSrVQE0i70FtmOrUaCdLWbcuDXM-M4TgpFPC5V66QTab7J-JvxeEzIy1ApkzMZUSGYoVwKeOd0klHNU64NZ2Jue3eu3ifLc366jteTyemoamnXymP1_eC-kv9BFcYAV9wl-w_IeqEwAN8BX_gEhOHzrzB-A67nA5vh8RtYWGXnHdzfOFvpVuBWoVrBvAKa24IIjXy7BpcHOFumqGYFQn455qfdCC7bKKzt9Pn2YlNvdzZTuqkbutRuvrPdr6-UJaCf6m9gamJIw352qeh3EN-Cja29g3Hji94yXdIBJrK-fA3mDOucgCnkFBdhx540HRvMfOQWIYrhh_11jHsQvLDjYkHhYcjLxreD1i--WgwhvsPUKxtmL19T2F-6Rq6HKfAoXKD_mPl8G_bBAe7rdk_Cc18deir2hnZy9onKL9HHz0W0I1ZydpvccuFE8LqzjTtkopu75MbKFUzcIyediQTORAJvIsFgIsGeiQR1EwwmEnQGcZ-cn7w9K5bUHZ1BFbxkLZXMmCqbgyIio4WRUma50sAG46wSlRBA5OGHZiqVqZB41kcYJVXFtOYq4xWLHpCjZtvoRyQwYaVCUWUsFprLPBEgJmXSKBkKYxIxJVGvp1K5vvJ4vMmX0saXcVaioktUdFksSpaWqOgpof5fF11flT_c_6KHoAQHiKtaotHb3VUJIUoa5zHEClPysIPES-yxnJJ0Dyx_AzZX37_S1BvbZB3igozx-PFvZT4hN4c34yk5ai93-hkQ1FY-t5b3A3A1jHw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BLIMP1+Induces+Transient+Metastatic+Heterogeneity+in+Pancreatic+Cancer&rft.jtitle=Cancer+discovery&rft.au=Chiou%2C+Shin-Heng&rft.au=Risca%2C+Viviana+I&rft.au=Wang%2C+Gordon+X&rft.au=Yang%2C+Dian&rft.date=2017-10-01&rft.eissn=2159-8290&rft.volume=7&rft.issue=10&rft.spage=1184&rft_id=info:doi/10.1158%2F2159-8290.CD-17-0250&rft_id=info%3Apmid%2F28790031&rft.externalDocID=28790031
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2159-8274&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2159-8274&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2159-8274&client=summon